These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25326403)

  • 1. Relation of asymmetric dimethylarginine and cardiac involvement in systemıc sclerosis.
    Dağ Ş; Budulgan M; Dilek B; Batmaz I; Arıtürk Z; Nas K; Çevik R
    Acta Reumatol Port; 2014; 39(3):228-35. PubMed ID: 25326403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.
    Dimitroulas T; Giannakoulas G; Papadopoulou K; Karvounis H; Dimitroula H; Koliakos G; Karamitsos T; Parcharidou D; Settas L
    J Rheumatol; 2010 May; 37(5):993-9. PubMed ID: 20194451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Sfetsios T; Karvounis H; Dimitroula H; Koliakos G; Settas L
    Rheumatology (Oxford); 2008 Nov; 47(11):1682-5. PubMed ID: 18753191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Irzyk K; Kostrubiec M; Bartoszewicz Z; Siwicka M; Stelmaszczyk-Emmel A; Górska E; Demkow U; Pruszczyk P
    Clin Rheumatol; 2014 Jan; 33(1):83-9. PubMed ID: 23942766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients.
    Meune C; Avouac J; Wahbi K; Cabanes L; Wipff J; Mouthon L; Guillevin L; Kahan A; Allanore Y
    Arthritis Rheum; 2008 Jun; 58(6):1803-9. PubMed ID: 18512815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damage.
    Meune C; Khanna D; Aboulhosn J; Avouac J; Kahan A; Furst DE; Allanore Y
    Semin Arthritis Rheum; 2016 Feb; 45(4):439-45. PubMed ID: 26272194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
    Jurisic Z; Martinovic-Kaliterna D; Marasovic-Krstulovic D; Perkovic D; Tandara L; Salamunic I; Carevic V
    Rheumatology (Oxford); 2013 Jul; 52(7):1298-302. PubMed ID: 23538743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
    Dooley A; Gao B; Bradley N; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
    Rheumatology (Oxford); 2006 Jun; 45(6):676-84. PubMed ID: 16399843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis.
    de Groote P; Gressin V; Hachulla E; Carpentier P; Guillevin L; Kahan A; Cabane J; Francès C; Lamblin N; Diot E; Patat F; Sibilia J; Petit H; Cracowski JL; Clerson P; Humbert M;
    Ann Rheum Dis; 2008 Jan; 67(1):31-6. PubMed ID: 17267515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study.
    Lindqvist P; Caidahl K; Neuman-Andersen G; Ozolins C; Rantapää-Dahlqvist S; Waldenström A; Kazzam E
    Chest; 2005 Aug; 128(2):755-63. PubMed ID: 16100164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study.
    Turiel M; Gianturco L; Ricci C; Sarzi-Puttini P; Tomasoni L; Colonna Vde G; Ferrario P; Epis O; Atzeni F
    Arthritis Care Res (Hoboken); 2013 Feb; 65(2):274-80. PubMed ID: 22899452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study.
    D'Alto M; Riccardi A; Argiento P; Di Stefano I; Romeo E; Iacono AM; D'Andrea A; Fasano S; Sanduzzi A; Bocchino M; Docimo L; Tolone S; Russo MG; Valentini G
    Clin Exp Med; 2018 May; 18(2):237-243. PubMed ID: 28993902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study.
    Pagkopoulou E; Soulaidopoulos S; Katsiki N; Malliari A; Loutradis C; Karagiannis A; Doumas M; Garyfallos A; Kitas G; Dimitroulas T
    Clin Rheumatol; 2023 Apr; 42(4):1077-1085. PubMed ID: 36534350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart structure and function in systemic sclerosis.
    Plazak W; Zabinska-Plazak E; Wojas-Pelc A; Podolec P; Olszowska M; Tracz W; Bogdaszewska-Czabanowska J
    Eur J Dermatol; 2002; 12(3):257-62. PubMed ID: 11978567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients.
    Chighizola C; Meroni PL; Schreiber BE; Coghlan JG; Denton CP; Ong VH
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S81-5. PubMed ID: 22691215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?
    Allanore Y; Wahbi K; Borderie D; Weber S; Kahan A; Meune C
    Ann Rheum Dis; 2009 Dec; 68(12):1885-9. PubMed ID: 19054819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension. Speckle-tracking echocardiographic study.
    Durmus E; Sunbul M; Tigen K; Kivrak T; Ozen G; Sari I; Direskeneli H; Basaran Y
    Herz; 2015 Jun; 40(4):709-15. PubMed ID: 24938219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of plasma asymmetric dimethylarginine (ADMA) levels and tissue doppler echocardiography for heart function in term infants born to mothers with gestational diabetes mellitus.
    Arslan D; Oran B; Vatansev H; Cimen D; Guvenc O
    J Matern Fetal Neonatal Med; 2013 Nov; 26(17):1742-8. PubMed ID: 23614659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.